To The Moon

$Eli Lilly(LLY)$ Poor doug is going to lose lots of money , Because many drugs in stage 3 trails like over 60 drugs that are way better than LLY's diet drug will hit the market in Q1 of 2025. . Plus the EU has said that they will not be using LLY's drug because they are way overprice for what little the patients get from them. Means the EU has its own companies they will be using

$Quantumscape Corp.(QS)$ To those who are new to QS. Bare in mind, QS Already has signed onto 4x contract’s with four OEM’s that are still hiding in the shadows waiting to put QS batteries in. We are not sure however who these companies are. All I can tell you is two of the 4 are major players. M

$Gevo(GEVO)$ couldnt resist a little nibble back in at 2.60. Rode this thing in 2021 from 2 to 12....mostly on enormous, short squeeze. One of my few big winners. Short volume no where close, but perhaps they will actually build the SAF facility. Lets see what happens near close.

$Intel(INTC)$ What's going on with my INTC?1- Layoff of 1300 employees2- China investigating INTC3- Qualcomm buying IntelLet's analyze:1- Layoff of 1300 employees ===> Means less expenses and more revenue for Intel ===> GOOD2- China investigating INTC ===> Who cares? Intel is already restricted from selling Intel Chips to China3- Qualcomm buying Intel ===> A good thing for stockholders? Maybe we all get $50 per INTC share?

$Microsoft(MSFT)$ At $13 earnings this year and $15 next year (likely $16 next year), giving a PE of 30, we have $390 to $450 and giving 40, we have $520 to $600. Of course, the high numbers are for next year’s earnings and we can expect shares to move to $450 to $600 range in 6 months to a year. Perhaps, looking for $500 a year from now will be a reasonable expectation. Given the AI tailwind, these EPS numbers may be conservative, making the probability of hitting 500 in the next year pretty high. Street may not like Mag 7, but one has no choice but to get behind them as that is where the money is! Cheers.

$Palantir Technologies Inc.(PLTR)$ Just consolidation, it went up a lot recently so has to absorb all the gains, before going higher. Normal movements.

$SIA(C6L.SI)$ The purchase was made based on the stock's chart pattern and the expectation of a decline in international oil prices, with a focus on a six-month time frame.From here on, it bottoms out and heads upwards 👆

$SSE Comp(000001.SH)$ I started trading stocks to support my family today with a principal of 70,000. My goal is to make enough for living expenses each month. On the first day, I chased high and got caught, losing 5%. Everything is difficult at the beginning, but I still have confidence.

$Direxion Daily FTSE China Bear 3X Shares(YANG)$ Market capitalization is a measure of a company's creditworthiness, and it seems these major shareholders are treating it as a convertible value to cash out. Various regions and provinces still view the stock market as an ATM, using it as a financing tool to take advantage of retail investors. My friends, let's all disperse and reclaim our valuable funds. Since there are no returns, there's no point in playing along. The trading value of the secondary market belongs to its shareholders. Since others who don't contribute anything are coming here to drain market funds in various ways, let's not participate. Let's adjourn. Those who are capable could significantly short sell,

$Alphabet(GOOG)$ The Nobel Prizes this year have truly embraced artificial intelligence in a comprehensive way. It was quite unexpected that yesterday's Nobel Prize in Physics was awarded to Geoffrey Hinton, who once led AI research at Google (with no disrespect intended for the great teacher Hinton). Today, the Nobel Prize in Chemistry was awarded to Demis Hassabis and John Jumper, who are currently working on AI at Google. Demis Hassabis, who used to be a game developer, closed his game development studio in 2009 and went on to pursue a Ph.D. in cognitive neuroscience at UCL. John Jumper is even more impressive; he is a post-85s generation who only graduated with a Ph.D. from the University of Chicago in 2017—truly, her